ICAM-1 peptide inhibitors of T-cell adhesion bind to the allosteric site of LFA-1. An NMR characterization.

This is the inserted domain of the human alfa-L chain chain of LFA-1 (UNIPROT P20701), and the numbering used ignores the signal sequence (residues 1-26 in the unprocessed polypeptide).
Residues 127-128 come from the cloning and do not belong to the native protein

Leukocyte Function Associated Antigen-1 Inserted-Domain

Crystal Structure Analysis Of The Complex Lfa-1 (cd11a) I-domain / Lovastatin At 2.6 A Resolution

Nmr Solution Structure Of The Inserted Domain Of Human Leukocyte Function Associated Antigen-1

Crystal Structure Of The Intermediate Affinity Al I Domain M

Crystal Structure Of Alphal I Domain In Complex With Icam-1

Crystal Structure Of High Affinity Alphal I Domain With Ligand Mimetic Crystal Contact

Crystal Structure Of High Affinity Alphal I Domain In The Absence Of Ligand Or Metal

An Allosteric Inhibitor Of Lfa-1 Bound To Its I-Domain

Structural Basis Of Icam Recognition By Integrin Alpahlbeta2 Revealed In The Complex Structure Of Binding Domains Of Icam-3 And

X-ray Structure Of Lfa-1 I-domain In Complex With Lfa703 At 2.2a Resolution

X-ray Structure Of Lfa-1 I-domain In Complex With Lfa878 At 2.1a Resolution

X-ray Structure Of Lfa-1 I-domain Bound To A 1,4-diazepane- 2,5-dione Inhibitor At 1.8a Resolution

Cd11a (Lfa1) I-Domain Complexed With Bms-587101 Aka 5-[(5s, 9r)-9-(4-Cyanophenyl)-3-(3,5-Dichlorophenyl)-1-Methyl-2,4- Dioxo-1,

Cd11a (Lfa1) I-Domain Complexed With 7a-[(4-Cyanophenyl) Methyl]-6-(3,5-Dichlorophenyl)-5-Oxo-2,3,5,7a-Tetrahydro- 1h-Pyrrolo[1

Crystal Structure Of Icam-5 In Complex With Al I Domain

Crystal Structure The Fab Fragment Of Efalizumab In Complex With Lfa-1 I Domain, Form I

Crystal Structure The Fab Fragment Of Efalizumab In Complex With Lfa-1 I Domain, Form Ii

Crystal Structure Of Wild Type Lfa1 I Domain

Crystal Structure Of Wild Type Lfa1 I Domain Complexed With Isoflurane

Crystal Structure Of Intermediate Affinity I Domain Of Integrin Lfa-1 With The Fab Fragment Of Its Antibody Al-57

Cd11a I-Domain Complexed With 6-((5s,9r)-9-(4-Cyanophenyl)-3 Dichlorophenyl)-1-Methyl-2,4-Dioxo-1,3,7- Triazaspiro[4.4]n Nicoti

Structure Of Engineered Single Domain Icam-1 D1 With High-affinity Al Integrin I Domain Of Native C-terminal Helix Conformation

X-ray Structure Of Lfa-1 I-domain In Complex With Ibe-667 At 1.8a Resolution

leukocyte function-associated molecule-1 alpha subunit [Homo sapiens]

leukocyte-associated molecule-1 alpha subunit [Pan troglodytes]

integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) [Homo sapiens]

integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide), isoform CRA_b [Homo sapi

integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide), isoform CRA_c [Homo sapi

integrin alpha-L isoform a precursor [Homo sapiens]

PREDICTED: integrin alpha-L [Macaca mulatta]

PREDICTED: integrin alpha-L isoform 1 [Gorilla gorilla gorilla]

PREDICTED: integrin alpha-L isoform X1 [Homo sapiens]

RecName: Full=Integrin alpha-L; AltName: Full=CD11 antigen-like family member A; AltName: Full=Leukocyte adhesion glycoprotein

Backbone 1H, 13C, and 15N chemical shift assignments for the LFA-1 wild type I-domain

Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax